BDX 250117 220.00P (BDX250117P220000) Stock Options, News & Quotes

0.04
-0.02-33.33%

15min DelayClose Jan 17 16:00 ET

0.04High0.04Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

103208831

Apr 18, 2024 11:43

$Becton Dickinson & Co (BDX.US)$ GAME OVER stock.

Moomoo AI

Feb 29, 2024 06:14

Despite a dip in earnings, Becton Dickinson's high P/E ratio persists due to anticipated robust future growth, outpacing the broader market. Investors' confidence in the company's future earnings is high, indicating the share price is unlikely to drop significantly soon.

Earnings Tell The Story For Becton, Dickinson and Company (NYSE:BDX)

Alvinnnnnnngenius

Dec 7, 2023 05:54

Big news

$Becton Dickinson & Co (BDX.US)$ BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

Moomoo AI

Nov 21, 2023 05:52

Dr. Silverman's extensive experience and zeal for innovation, evidence generation, clinical development, medical safety, and compliance is predicted to boost BD's innovation pipeline and foster improved, personalized care.

Press Release: BD Names Dr. Ronald Silverman as Chief Medical Officer

Moomoo AI

Oct 10, 2023 11:30

Market sentiment towards Becton, Dickinson and Company shows no major shift in the past year. However, the rise in total shareholder return hints at a growing positivity.

Investing in Becton Dickinson (NYSE:BDX) a Year Ago Would Have Delivered You a 15% Gain